The in vitro diagnostics (IVD) industry, as a core supporting track in the medical and health field, relies on upstream reagent raw materials as the cornerstone of diagnostic reagent research and mass production. Its price trend and supply stability directly affect the cost control and production rhythm of the entire industry chain. At present, the domestic and even global IVD reagent raw material market presents a pattern of periodic price fluctuations and supply stability coexisting with demand. While the market size continues to expand, the risk of price fluctuations always exists. Enterprises with stable supply and cost control capabilities are better able to gain an advantage in industry competition.

Chemiluminescence reagent

1、 The core cause of price fluctuations: resonance between cost structure and production factors

The fluctuation of IVD reagent raw material prices is mainly due to the combined effect of multiple production factors and cost structures, and is the result of the combination of industry endogeneity and external environment, rather than being driven by a single factor.

From the perspective of production costs, the cost of core raw materials and intermediates accounts for a relatively high proportion. These raw materials are mostly biological agents and specialized chemical substrates, and some rely on specific bacterial strains for fermentation and imported raw material purification. The scarcity of resources and production restrictions are obvious, and their procurement prices are greatly affected by international supply chains, environmental management, and raw material supply and demand. The price increase of upstream raw materials will directly transmit to the pricing of terminal IVD raw materials.

Production equipment and technology investment are both rigid cost items. IVD reagent raw materials have strict requirements for purity and activity, and production requires high-precision purification and sterile automation equipment. Enterprises need to continue investing in equipment maintenance and process iteration. The early-stage research and equipment costs brought about by technological upgrades will be shared among the product unit price, further exacerbating price fluctuations.

2、 Supply and demand pattern: key external regulatory force for price fluctuations

The market supply and demand relationship is the core external factor that influences the price trend of IVD reagent raw materials. The expansion of demand and supply barriers together determine the magnitude of price fluctuations.

The demand side continues to improve, with an aging population, widespread screening of chronic diseases, and normalization of public health prevention and control, driving the steady increase in demand for IVD diagnostic reagents, which in turn drives the growth of demand for core raw materials such as upstream enzyme preparations, biological buffering agents, and chemiluminescence reagents. During the stage of concentrated demand release, there is a risk of periodic supply shortages, driving up prices.

There are obvious barriers on the supply side, with high technical barriers and strict quality control standards for IVD reagent raw material production. The number of enterprises with stable production capacity on a large scale is limited, and some raw materials still rely on imports, resulting in relatively concentrated supply channels. Once core suppliers experience capacity reduction, logistics disruptions, policy adjustments, and other situations, market supply will tighten and prices will fluctuate rapidly;

3、 Breaking the deadlock with stability: the core measure of Hubei Xindesheng to cope with market fluctuations

In the face of frequent price fluctuations and increased supply chain uncertainty in the market environment, the core competitiveness of IVD raw material enterprises lies in building a stable control system throughout the entire process, hedging external risks, and ensuring downstream customer production continuity. Hubei Xindesheng has formed an effective fluctuation response plan with mature operations and technological layout.

On the supply chain side, Hubei Xindesheng has established diversified procurement channels, abandoned reliance on a single raw material supply, signed long-term stable cooperation agreements with multiple upstream core raw material suppliers, and reserved sufficient safety stock in advance to avoid short-term price increases and supply disruptions of raw materials, locking in basic costs from the source and avoiding rapid transmission of upstream price fluctuations to end products.

The production end achieves cost reduction and efficiency improvement through refined control and process optimization, relying on standardized mass production lines to improve unit capacity utilization and reduce production costs for individual products; At the same time, establish a comprehensive quality control system to ensure that core indicators such as product purity and activity meet the standards, and that performance deviations between batches are controllable. There is no need for rework or loss due to unqualified products, indirectly reducing overall costs and maintaining stable product prices.

enzyme preparation

In response to market fluctuations, Hubei Xindesheng adheres to a reasonable pricing strategy, does not blindly follow the trend of price increases, relies on its own research and production advantages, balances costs and prices, and provides downstream IVD enterprises with high-purity, batch stable, and timely supply of raw material products, covering multiple categories such as biological buffering agents, enzyme preparations, chemiluminescence substrates, etc., to meet customer mass production needs and help downstream enterprises avoid production risks caused by raw material price fluctuations.